STAT5驱动常染色体显性多囊肾病中的异常增殖
研究通过siRNA筛选发现多个JAK-STAT成员(包括STAT1、STAT2、STAT4、STAT5a、STAT5b)具有促增殖作用,并聚焦生长激素/生长激素受体/STAT5轴。药理学抑制或siRNA降低STAT5功能可显著减少体外增殖并减少囊肿生长;两种独立小鼠模型显示囊肿衬里细胞核内STAT5激活;生长激素过表达增加肾脏STAT5活性并与cyclin D1表达相关;Pkd1突变小鼠血清生长激素升高。结论:生长激素/STAT5信号轴是ADPKD的新治疗靶点。
要点
- siRNA筛选发现STAT1、STAT2、STAT4、STAT5a、STAT5b具有促增殖作用。
- 抑制STAT5功能可显著减少体外增殖并减少囊肿生长。
- 两种ADPKD小鼠模型囊肿衬里细胞中STAT5呈核内激活。
核心结论
- 生长激素/STAT5信号轴是ADPKD的新治疗靶点。
研究设计与样本
- 采用siRNA JAK-STAT聚焦筛选,并分析两种独立ADPKD小鼠模型及生长激素过表达小鼠。
主要发现
- siRNA筛选发现多个JAK-STAT成分(包括STAT1、STAT2、STAT4、STAT5a、STAT5b)具有此前未知的促增殖作用。
- 药理学抑制或siRNA降低STAT5功能显著减少增殖,并伴随体外囊肿生长减少。
- 两种独立ADPKD小鼠模型的肾上皮囊肿衬里细胞中STAT5呈核内表达(即激活)。
- 生长激素过表达小鼠肾上皮细胞STAT5活性增加,与STAT5靶基因cyclin D1的从头表达相关。
- 染色质免疫沉淀实验显示STAT5以生长激素依赖方式转录激活cyclin D1;Pkd1突变小鼠血清生长激素升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal dominant polycystic kidney disease (ADPKD) leads to renal failure. The hallmark of ADPKD is increased epithelial proliferation, which has been proposed to be due to atypical signaling including abnormal JAK-STAT activity. However, the relative contribution of JAK-STAT family members in promoting proliferation in ADPKD is unknown. Here, we present siRNA JAK-STAT-focused screens discovering a previously unknown proliferative role for multiple JAK-STAT components (including STAT1, STAT2, STAT4, STAT5a, and STAT5b). Amongst these, we selected to study the growth hormone/growth hormone receptor/STAT5-axis because of its known role as a regulator of growth in nonrenal tissues. Loss of STAT5 function, facilitated by pharmacological inhibition or siRNAs, significantly reduced proliferation with an associated reduction in cyst growth in vitro. To study whether STAT5 is abnormally activated in vivo, we analyzed its expression using two independent mouse models of ADPKD. STAT5 was nuclear, thus activated, in renal epithelial cyst lining cells in both models. To test whether forced activation of STAT5 can modulate proliferation of renal cells in vivo, irrespective of the Pkd1 status, we overexpressed growth hormone. These mice showed increased STAT5 activity in renal epithelial cells, which correlated with de novo expression of cyclin D1, a STAT5 target gene. Chromatin immunoprecipitation experiments revealed that STAT5 transcriptionally activated cyclin D1 in a growth hormone-dependent fashion, thus providing a mechanism into how STAT5 enhances proliferation. Finally, we provide evidence of elevated serum growth hormone in Pkd1 mutant mice. Thus, the growth hormone/STAT5 signaling axis is a novel therapeutic target in ADPKD.
引用
- Fragiadaki M, Lannoy M, Themanns M, et al. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. Kidney Int. 2017. PMID: 28104302. doi:10.1016/j.kint.2016.10.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。